Suppr超能文献

心力衰竭与骨质疏松症:老年人群面临的共同挑战

Heart Failure and Osteoporosis: Shared Challenges in the Aging Population.

作者信息

Spoladore Roberto, Ciampi Claudio Mario, Ossola Paolo, Sultana Andrea, Spreafico Luigi Paolo, Farina Andrea, Fragasso Gabriele

机构信息

Heart Failure Clinic, Division of Cardiology, Alessandro Manzoni Hospital, ASST Lecco, 23900 Lecco, Italy.

Health Science Department, University of Milan Bicocca, 20126 Milan, Italy.

出版信息

J Cardiovasc Dev Dis. 2025 Feb 13;12(2):69. doi: 10.3390/jcdd12020069.

Abstract

In clinical practice, heart failure (HF) and osteoporosis (OP) are commonly paired conditions. This association is particularly relevant in patients over the age of 50, among whom its prevalence increases dramatically with every decade of life. This can be especially impactful since patient prognosis when facing both conditions is poorer than that of each disease alone. Clinical studies suggest that prior fractures increase the risk for heart failure hospitalization and, conversely, an episode of heart failure increases the risk of subsequent fractures. In other words, the relationship between osteoporosis and heart failure seems to be two-way, meaning that each condition may influence or contribute to the development of the other. However, the details of the pathophysiological relationship between HF and OP have yet to be revealed. The two conditions share multiple pathological mechanisms that seem to be intertwined. Patients affected by OP are more prone to develop HF because of vitamin D deficiency, elevation of parathyroid hormone (PTH) plasma levels, and increased Fibroblast Growth Factor 23 (FGF-23) activity. On the other hand, HF patients are more prone to develop OP and pathological fractures because of low vitamin D level, high PTH, chronic renal failure, alteration of renin-angiotensin-aldosterone system, reduced testosterone level, and metabolic effects derived from commonly used medications. Considering the increasingly aging worldwide population, clinicians can expect to see more often an overlap between these two conditions. Thus, it becomes crucial to recognize how HF and OP mutually influence the patient's clinical condition. Clinicians attending these patients should utilize an integrated approach and, in order to improve prognosis, aim for early diagnosis and treatment initiation. The aim of this paper is to perform a review of the common pathophysiological mechanisms of OP and HF and identify potentially new treatment targets.

摘要

在临床实践中,心力衰竭(HF)和骨质疏松症(OP)是常见的并存病症。这种关联在50岁以上的患者中尤为显著,随着年龄每增长十岁,其患病率会急剧上升。这可能具有特别重大的影响,因为同时患有这两种病症的患者预后比单独患每种疾病的患者更差。临床研究表明,既往骨折会增加心力衰竭住院的风险,反之,一次心力衰竭发作会增加后续骨折的风险。换句话说,骨质疏松症和心力衰竭之间的关系似乎是双向的,即每种病症可能会影响或促成另一种病症的发展。然而,HF和OP之间病理生理关系的细节尚未明了。这两种病症共享多种似乎相互交织的病理机制。患有OP的患者更容易因维生素D缺乏、甲状旁腺激素(PTH)血浆水平升高和成纤维细胞生长因子23(FGF - 23)活性增加而发生HF。另一方面,HF患者更容易因维生素D水平低、PTH高、慢性肾衰竭、肾素 - 血管紧张素 - 醛固酮系统改变、睾酮水平降低以及常用药物的代谢作用而发生OP和病理性骨折。考虑到全球人口老龄化日益加剧,临床医生可能会更频繁地遇到这两种病症的重叠情况。因此,认识到HF和OP如何相互影响患者的临床状况变得至关重要。诊治这些患者的临床医生应采用综合方法,为改善预后,力求早期诊断并开始治疗。本文的目的是对OP和HF的常见病理生理机制进行综述,并确定潜在的新治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d8/11856909/155474395728/jcdd-12-00069-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验